Exclusive Summary

• An off-patent, WHO Essential Medicine driven by rigid demand from hundreds of millions of surgeries and dental procedures annually, empowering distributors with rapid monetization.
• The universally recognized "gold standard" and first-line treatment for local anesthesia and cardiac arrhythmias, requiring zero market education for downstream clinicians.
• Backed by China's integrated API-to-finished-product supply chain, it offers aggressive pricing and reliable supply, effectively resolving the frequent global shortages of sterile injectables.